Dr William Duncan Potter, PhD
Executive Chairman
Dr Potter became Chairman in June 2001. He is a member of the Nominations Committee and an adviser to the Remuneration Committee. He provides advice and expertise on product development matters bringing to bear his considerable experience. He has spent 36 years in research and development including 28 years of bringing new products to market involving a wide range of medical devices. He has extensive knowledge of worldwide regulatory procedures, intellectual property issues and licensing. Dr Potter previously worked at London International Group plc, including 7 years as Group Scientific Affairs Director and at Smith & Nephew plc.
James Henry Barder
Chief Executive
Mr Barder joined the Company as Chief Executive in June 2001. He assists the Remuneration and the Nominations Committees (but is not a member of and does not vote on either). He has overall responsibility for all activities of the Group, is a principal contact for all shareholder and investor relations matters and leads licensing and distribution negotiations and new product development activities. He first became involved with the Group as an investor in 1997 and has been a Director of the subsidiary since 1998. Prior to becoming Chief Executive, he was Managing Director of Aon Capital Markets Limited. Mr Barder has predominantly worked in the field of insurance and finance including firms he founded and co-owned. Mr Barder is also a Non-Executive Director of Lorega Limited and Creon Corporation plc .
David Bryn Davies, BSc (Hons), MBA
Product Development Director
Mr Davies has been a Director of the Company since September 2001. He is responsible for all product development programs for the Group. Prior to joining the Company, Mr Davies was Director of Project Management at Clintrials Research Ltd. He has 24 years of experience of pharmaceutical and healthcare product development, within pharmaceutical companies and global contract clinical research organisations. Previous employers include Porton Down, Glaxo Group Research, Wellcome Research Ltd, Zambon Limited and PPD Pharmaco Ltd. Mr Davies is Company Secretary of the charity Ordinary 2 Extraordinary Limited and a trustee of the Gary Evans Charitable Trust.
Jonathan David Freeman, BA (Hons), MBA
Senior Independent Non-Executive Director
Chairman of Remuneration and Audit Committees
Mr Freeman joined the Board in July 2003 and was appointed Senior Independent Non-Executive Director in November 2003. As well as chairing the Audit and the Remuneration Committees, he is also a member of the Nominations Committee. He provides guidance on City regulatory matters, corporate finance and investor relations. He provides over 15 years of corporate finance experience with previous roles including; Partner at Gambit Corporate Finance, Director of Beeson Gregory and involvement in the creation of EASDAQ. Mr Freeman is also an Executive Director of Creon Corporation plc and a Non-Executive Director of AIM-quoted Cobra Capital Limited, Equity Pre IPO Investments Limited and Syndicate Asset Management plc.
Lisa Arnold
Independent Non-Executive Director
Chair of Nominations Committee
Ms Arnold joined the Board in March 2008. As well as chairing the Nominations Committee, she is also a member of the Remuneration and the Audit Committees. She has extensive experience of the investment and healthcare sectors. She worked in the investment banking industry from 1984 to 2001, holding senior positions including sector head of pharmaceuticals and healthcare at UBS and Commerzbank. Since 2001, Ms Arnold has worked in consultancy and non-executive roles predominantly in the pensions, healthcare and technology sectors. She is currently a Non-Executive Director of the UK’s Medicines & Healthcare Products Regulatory Agency (MHRA), where she also chairs the Risk & Audit committee, and an adviser to the Allied Domecq Pension Funds and the Kraft UK Pension Fund (Trustees).
Derek Martin
Finance Director
Company Secretary
Mr Martin joined the Company as Financial Controller in April 2007, became Company Secretary in May 2008 and joined the Board as Finance Director in September 2008. He oversees the Group's finance function and also its compliance procedures. Mr Martin qualified as a Chartered Accountant in 1984 and has more than 20 years' experience of a variety of senior accounting roles in a diverse range of industries including software, retail, telecoms and media. Mr Martin's recent roles have included positions of Financial Controller at Links of London, the jewellery chain, and Entuity Limited, a US software development company.